Zobrazeno 1 - 10
of 36
pro vyhledávání: ''
Autor:
Ani Melani Maskoen, Abdurachman Sukadi, Heda Melinda Nataprawira, Alvinsyah Adhityo Pramono, Achmad Headriawan, Alex Chairulfatah
Publikováno v:
The Application of Clinical Genetics
Achmad Headriawan,1 Alvinsyah Adhityo Pramono,2 Abdurachman Sukadi,1 Alex Chairulfatah,1 Ani Melani Maskoen,2,3 Heda Melinda Nataprawira1 1Department of Child Health; 2Research Center of Medical Genetics; 3Department of Biomedical Sciences, Faculty o
Autor:
Siti Hajar Rehiman, Fei Tieng Lim, Shahrul Bahyah Kamaruzzaman, Abu Bakar Abdul Majeed, Maw Pin Tan, Siong Meng Lim, Kalavathy Ramasamy, Ai-Vyrn Chin
Publikováno v:
International Journal of Neuroscience. 132:1014-1025
Objective: Alzheimer’s disease (AD), the commonest form of dementia which is characterized by progressive decline in cognitive function, can only be definitively diagnosed after death. Although bio...
Autor:
Sergej M. Ostojic
Publikováno v:
Nutritional Neuroscience. 25:912-919
Multiple sclerosis (MS) is a complex and debilitating neurodegenerative disease, with unknown cause(s), unpredictable prognosis, and rather limited treatment options. MS is often accompanied by various metabolic disturbances, with impaired creatine m
Publikováno v:
International Journal of Neuroscience. 132:237-247
The aim of this study was to evaluate the safety and effectiveness of rotigotine under daily clinical practice in Parkinson's disease patients.The study was a prospective, non-interventional, observational study targeting patients who were treated wi
Autor:
G. Piuri, S. Caronni, S.A. Faierman, O.V. Donnarumma, Carlotta Bolliri, Chiara Pusani, Giovanna Pinelli, Michela Barichella, Erica Cassani, Gianni Pezzoli, E. Vaccarella, Emanuele Cereda, F. Valentina
Publikováno v:
Nutritional Neuroscience. 25:246-255
Weight homeostasis is complex in Parkinson's disease (PD) and body weight changes substantially throughout the course of the disease. We designed a case-control study to i) investigate whether PD is associated with changes in resting energy expenditu
Publikováno v:
The Application of Clinical Genetics. 13:37-47
The last 15 years have been the most fruitful in the history of research on the metabolic disorder alkaptonuria (AKU). AKU is caused by a deficiency of homogentisate dioxygenase (HGD), the enzyme involved in metabolism of tyrosine, and is characteriz
Autor:
Hani Alothaid, Mohammed S K Aldughaim, Sufana AlMashhadi, Karim El Bakkouri, Ahmed A. Al-Qahtani
Publikováno v:
Channels
article-version (VoR) Version of Record
article-version (VoR) Version of Record
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has prompted an urgent need to identify effective medicines for the prevention and treatment of the disease. A comparative analysis between SARS-CoV-2 and
Publikováno v:
International Journal of Neuroscience. 129:384-392
L-dopa remains the most effective symptomatic therapy for Parkinson's disease (PD) but unfortunately, its chronic use is often associated with motor complications. This review highlights the importance of pharmacogenetics in an individualised PD ther
Autor:
Joseph Jankovic, Hassaan Bashir
Publikováno v:
Expert Review of Neurotherapeutics. 18:625-631
Huntington's disease (HD) is an inherited neurodegenerative disorder for which no disease-modifying treatment is currently available. Only symptomatic treatment can be offered. Chorea is the most common motor manifestation of HD and may interfere wit
Autor:
Thomas Müller, Jan-Dominique Möhr
Publikováno v:
Expert Opinion on Pharmacotherapy. 19:1003-1011
Parkinson's disease is a chronic, neurodegenerative disease. Its symptoms and course are heterogeneous. After several years of investigative drug studies, levodopa remains the most efficacious drug despite its long-term limitations. Consequently, res